Holen Sie sich die Stockscreener-App
2.00
1.48%
-0.03
Handel nachbörslich:
2.00
Biovie Inc Aktie (BIVI) Neueste Nachrichten
Biovie Stock Price Forecast. Should You Buy BIVI? - StockInvest.us
Jane Street reports over 5% stake in BioVie (BIVI) - Stock Titan
Small cap wrap: Alvopetro, Royal Road Minerals, Nextech3D.ai, TNR Gold... - Proactive financial news
Market movers: PG&E, Aon, Eli Lilly, BioVie... - Proactive financial news
BioVie completes final patient visit in Phase 2 Long COVID trial, topline results due by September 2026 - Pluang
BioVie (BIVI) Completes Final Visit in ADDRESS-LC Phase 2 Trial for Long COVID Neurological Symptoms - GuruFocus
BioVie Announces Completion of Treatment Phase of - GlobeNewswire
Dow falls as US strikes Iran, rate-hike bets jump - proactiveinvestors.co.uk
BioVie completes final patient visit in Phase 2 Long COVID trial - Proactive financial news
Price to earnings forward of BioVie Inc. – BOATS:BIVIW - TradingView
Biovie CFO Joanne Kim buys $5,450 in Biovie Inc. stock By Investing.com - Investing.com Australia
Insider Stock Purchases: August 29, 2026 - Moomoo
BioVie Stock (BIVI) Opinions on Phase 2 Trial Results - Quiver Quantitative
BioVie Inc. CEO Cuong V Do buys $31,636 in company stock - Investing.com India
Biovie director Amy Chappell acquires $1,570 in BIVI common stock By Investing.com - Investing.com India
BioVie Inc (BIVI) Chief Medical Officer Joseph Palumbo Buys 4,84 - GuruFocus
Biovie CMO Joseph Palumbo buys $10,460 in common stock By Investing.com - Investing.com India
BioVie (BIVI) CEO makes 15,210-share open-market buy - Stock Titan
Biovie CFO Joanne Kim buys $5,450 in Biovie Inc. stock - Investing.com
Biovie CMO Joseph Palumbo buys $10,460 in common stock - Investing.com
Anixa Biosciences Inc. (ANIX) Peer Comparison – Compare with Others - valueresearchonline.com
BioVie (BIVI) Shares: Moves 9.74% Up to $2.14 in the Latest Session; Boundary Watch - vinanet.vn
BioVie (BIVI) Results at a Glance: EPS Prints Above Forecast in the Current Update; Stock Move: The Stock Ends Up 4.84% at the CloseEarnings Sentiment Score - vinanet.vn
Number of shareholders of BioVie Inc. – NASDAQ:BIVIW - TradingView
New to The Street Broadcasts Today Across Bloomberg Television U.S., Latin America and MENA at 6:30 PM ET - Newswire.com
BioVie (BIVIW) Trading: Records a 1.75% Decrease to $0.28 in the Latest Session; the Supplied Trading Band Runs From $0.27 to $0.29 on the DayIndex Put Call - vinanet.vn
BIVI Jumps As BioVie Reports Strong Parkinson’s Trial Data - StocksToTrade
BioVie Inc.Warrant (Nasdaq:BIVIW) Stock Quote - FinancialContent
BIVI Stock Pops As SUNRISE-PD Parkinson’s Data Fuel Hype - timothysykes.com
BioVie (BIVI) Jumps As SUNRISE-PD Data Fuel Bullish Hopes - StocksToTrade
Which stocks are moving before the opening bell on Friday? - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
BioVie (BIVI) Financial Update: Profit Per Share Surpasses Its Benchmark in Latest Trading; Share Response: Shares Close 38.81% Higher on the DayWeak Earnings Momentum - vinanet.vn
MicroCaps IGC, BIVI, ORBS, RIME Sub-$1 Stocks to Watch Now - Barchart.com
BioVie (BIVI) Revenue BreakdownMain Composition - Moomoo
$BioVie (BIVI.US)$ told yall yesterday - Moomoo
BIVI Stock Draws Trader Focus After Strong Parkinson’s Data - StocksToTrade
BIVI Stock Draws Attention After Strong Parkinson’s Data - StocksToTrade
$BioVie (BIVI.US)$ Ready for lift off - Moomoo
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
New 8.4% BioVie (NASDAQ: BIVI) stake sits entirely in warrants - Stock Titan
BIVI Stock In Focus After SUNRISE-PD Trial Breakthrough - StocksToTrade
BIVI Stock Pops As Parkinson’s Drug Data Fuels Momentum - StocksToTrade
BIVI Stock In Play After Positive Parkinson’s Trial Data - timothysykes.com
Top Premarket Gainers - marketscreener.com
BIVI Q2 2026 Earnings: EPS Beat of 5.99% Offers Little Shelter as Shares Slide 5.56%Operating Income Trends - vinanet.vn
First Phosphate and BioVie Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV - New Castle News
BioVie Phase 2b Parkinson’s Trial Meets Primary Endpoint - Minichart
BioVie Inc. (BIVI) Holds Steady at $1.56 as Shares Consolidate Between Key Support and ResistanceBollinger Squeeze - vinanet.vn
BioVie Inc. Reports Earnings Results for the Full Year Ended June 30, 2026 - marketscreener.com
These stocks have an unusual volume in today's session - ChartMill
BioVie Q4 Results: EPS loss narrows 51% YoY to $(0.70) - scanx.trade
BIVI Stock Jumps As SUNRISE-PD Data Fuels Parkinson’s Hopes - timothysykes.com
BIOVIE INC. FY 2026: Net loss $22.1M — 10-K Summary - TradingView
Biotech Stocks At 52-Week HighsBIVI +22%, XNCR, ANRO, HAE, ACAD - RTTNews
BioVie Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
BIVI Stock Jumps As SUNRISE-PD Data Fire Up Parkinson’s Hopes - StocksToTrade
BIVI Stock Jumps As SUNRISE-PD Data Ignites Parkinson’s Hopes - timothysykes.com
These stocks are the most active in today's session - ChartMill
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
0.86%
0.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):